Miriam Mena-De - Publications

Epidemiological characterization of biliary tract cancer in a real-world cohort of patients from the Spanish TTD-RETUD gastrointestinal registry.

Journal: ESMO real world data and digital oncology

Published: August 22, 2026

MDM2 amplification in a real-world cohort of patients with biliary tract cancer from the Spanish RETUD gastrointestinal registry.

Journal: ESMO gastrointestinal oncology

Published: February 06, 2026

External validation of a prediction model for bleeding events in anticoagulated cancer patients with venous thromboembolism (PredictAI).

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: January 11, 2025

Characterization of thrombosis risk in ambulatory patients with cancer: results of the observational, prospective, multicenter CARTAGO study.

Journal: The oncologist

Published: June 13, 2024

Relationship between oral microbiota and colorectal cancer: A systematic review.

Journal: Journal of periodontal research

Published: March 14, 2024

Validation of the CoVID-TE model as a tool to predict thrombosis, bleeding, and mortality in the oncology patient with Sars-Cov-2 infection: a study by the SEOM cancer and thrombosis group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: March 01, 2023

Immune checkpoint inhibitor-associated thrombosis in patients with bladder and kidney cancer: a study of the Spanish Society of Medical Oncology (SEOM) thrombosis and cancer group.

Journal: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico

Published: February 14, 2023

Nutritional assessment and intervention in hospitalized cancer patients at risk of or with malnutrition: evaluation of the effect on anthropometric and body composition parameters

Journal: Nutricion hospitalaria

Published: December 01, 2022

Programmed Death-Ligand 1 (PD-L1) as Immunotherapy Biomarker in Breast Cancer.

Journal: Cancers

Published: November 05, 2021

Update on systemic treatment in early triple negative breast cancer.

Journal: Therapeutic advances in medical oncology

Published: September 14, 2020